Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Journal of Translational Medicine
|
December 17, 2009
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
Ioannis Alagkiozidis, Andrea Facciabene, Carmine Carpenito, et al.
Journal of Hepatology
|
August 9, 2021
Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A
Hui Xu, Stephen Locarnini, Darren Wong, et al.
United European Gastroenterology Journal
|
June 12, 2014
Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients
Cosmas Rinaldi Adithya Lesmana, Kathy Jackson, Seng Gee Lim, et al.
The American Journal of Pathology
|
April 25, 2009
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes
Hong Yu, Ronan McDaid, John Lee, et al.
Cancer Research
|
June 3, 2010
Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer
Carmen Z Michaylira, Gabrielle S Wong, Charles G Miller, et al.
Human Pathology
|
April 29, 2008
Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis
Xiaowei Xu, Phyllis A Gimotty, Dupont Guerry, et al.
Cancer Biology & Therapy
|
July 26, 2011
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma
Andrea R Hagemann, Ian S Hagemann, Mark Cadungog, et al.
Journal of Gastroenterology and Hepatology
|
January 11, 2013
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α
Jacinta A Holmes, Tin Nguyen, Dilip Ratnam, et al.
Gut
|
August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
Julianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Journal of Translational Medicine
|
December 17, 2009
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
Ioannis Alagkiozidis, Andrea Facciabene, Carmine Carpenito, et al.
Journal of Hepatology
|
August 9, 2021
Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A
Hui Xu, Stephen Locarnini, Darren Wong, et al.
United European Gastroenterology Journal
|
June 12, 2014
Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients
Cosmas Rinaldi Adithya Lesmana, Kathy Jackson, Seng Gee Lim, et al.
The American Journal of Pathology
|
April 25, 2009
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes
Hong Yu, Ronan McDaid, John Lee, et al.
Cancer Research
|
June 3, 2010
Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer
Carmen Z Michaylira, Gabrielle S Wong, Charles G Miller, et al.
Human Pathology
|
April 29, 2008
Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis
Xiaowei Xu, Phyllis A Gimotty, Dupont Guerry, et al.
Cancer Biology & Therapy
|
July 26, 2011
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma
Andrea R Hagemann, Ian S Hagemann, Mark Cadungog, et al.
Journal of Gastroenterology and Hepatology
|
January 11, 2013
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α
Jacinta A Holmes, Tin Nguyen, Dilip Ratnam, et al.
Gut
|
August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
Julianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Page
of 4